DexCom

Yahoo Finance • 2 days ago

Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a Farm & more

Check out some of the companies making the biggest moves midday: Adobe — The software giant saw shares tumble more than 5%. CEO Shantanu Narayen said that he would step down from his post after a successor has been named. Narayen will rema... Full story

Yahoo Finance • 10 days ago

Elfun Trusts Exits Texas Instruments Inc, Impacting Portfolio by -1.57%

This article first appeared on GuruFocus. Exploring the Strategic Moves in Elfun Trusts (Trades, Portfolio)' Fourth Quarter 2025 N-PORT Filing Warning! GuruFocus has detected 5 Warning Signs with NVDA. Is NVDA fairly valued? Test your th... Full story

Yahoo Finance • 12 days ago

1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside. Investing... Full story

Yahoo Finance • 17 days ago

Dexcom Appoints Rick Osterloh to Board of Directors

SAN DIEGO, February 26, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a... Full story

Yahoo Finance • 17 days ago

Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership

Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time highs in Q4 2025, with the S&P 500 Index r... Full story

Yahoo Finance • 18 days ago

DXCM March 2027 Options Begin Trading

Investors in DexCom Inc (Symbol: DXCM) saw new options become available today, for the March 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 387 days until... Full story

Yahoo Finance • 18 days ago

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars

Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of conditions linked to obesity. The drugmakers that... Full story

Yahoo Finance • 20 days ago

DexCom Breaks Above 200-Day Moving Average - Bullish for DXCM

In trading on Monday, shares of DexCom Inc (Symbol: DXCM) crossed above their 200 day moving average of $74.11, changing hands as high as $74.41 per share. DexCom Inc shares are currently trading up about 1.6% on the day. The chart below... Full story

Yahoo Finance • 21 days ago

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

Wall Street’s major market averages concluded higher on Friday as investors reacted to the latest PCE inflation report, which came in hotter than expected. The tech-focused Nasdaq Composite ended +0.9%. At the same time, the benchmark S&P... Full story

Yahoo Finance • 29 days ago

Stocks Settle Slightly Higher as Bond Yields Fall

The S&P 500 Index ($SPX) (SPY) on Friday closed up +0.05%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.18%.  March E-mini S&P futures (ESH26) rose +0.03%, and March E... Full story

Yahoo Finance • 30 days ago

Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations

Dexcom has achieved revenues of $4.66bn in 2025 and beat analysts’ consensus for Q4 performance amid a strong demand for its continuous glucose monitoring (CGM) systems. Yet its 2026 outlook was lower than expected. The company’s 2025 rev... Full story

Yahoo Finance • 30 days ago

Frank Sands Reduces Stake in Taiwan Semiconductor Manufacturing Co Ltd by 26.22%

This article first appeared on GuruFocus. Insights from Frank Sands (Trades, Portfolio)' Fourth Quarter 2025 13F Filing Warning! GuruFocus has detected 5 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our free DCF... Full story

Yahoo Finance • 30 days ago

Soleus Adds a Significant Number of Celcuity Shares

Key Points Soleus increased its Celcuity stake by 629,398 shares. The firm held over 1.8 million shares at the end of the quarter. Celcuity now accounts for 6.7% of fund AUM10 stocks we like better than Celcuity › On Feb. 12, Soleus Capi... Full story

Yahoo Finance • 30 days ago

DexCom outlines 2026 revenue growth of 11%-13% with G7 15 Day rollout and international expansion

Earnings Call Insights: DexCom, Inc. (DXCM) Q4 2025 MANAGEMENT VIEW * Jacob Leach, President, CEO & Director, marked his first call as CEO by outlining three strategic priorities: "We will be the premier glucose sensing solution for al... Full story

Yahoo Finance • last month

DexCom Stelo AI Upgrade Aims To Deepen Consumer Metabolic Health Engagement

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. DexCom (NasdaqGS:DXCM) announced new AI-enabled features for its Stelo glucose monitoring system... Full story

Yahoo Finance • last month

Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM

As the fourth-quarter earnings season unfolds, the ongoing week represents a key reporting window for several medical-sector companies. According to the latest Earnings Preview report, the Medical sector’s earnings likely faced pressure f... Full story

Yahoo Finance • last month

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors Inaugural launch of Omnipod Discover... Full story

Yahoo Finance • 2 months ago

2 Growth Stocks to Buy For 2026 and Beyond

Key Points Vertex could have several catalysts in 2026, helping it set a strong foundation for the future. DexCom is expanding its addressable market in order to help deal with some current challenges. 10 stocks we like better than Vertex... Full story

Yahoo Finance • 3 months ago

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In DexCom (DXCM) To Contact Him Directly To Discuss Their Options If you purchased or acquired DexCom securities between July 26, 2024... Full story

Yahoo Finance • 3 months ago

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “th... Full story